Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.4143/crt.2020.585
PubMed Identifier: 33070556
Publication URI: http://europepmc.org/abstract/MED/33070556
Type: Journal Article/Review
Volume: 53
Parent Publication: Cancer research and treatment
Issue: 2
ISSN: 1598-2998